Innoviva, Inc. (INVA) vs Kestra Medical Technologies, Ltd. (KMTS)
A side-by-side comparison of Innoviva, Inc. and Kestra Medical Technologies, Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
INVA
Innoviva, Inc.
$20.83HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
KMTS
Kestra Medical Technologies, Ltd.
$27.10HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — INVA vs KMTS
growth of $100 · dividends reinvested · last 2yINVA +17.2% (+8.3%/yr)KMTS +29.8% (+13.9%/yr)KMTS compounded faster over this window
INVA KMTS
INVA vs KMTS: by the numbers
- •KMTS is the larger company ($1.59B vs $1.54B market cap).
- •INVA is profitable (80.56% net margin) while KMTS runs a net loss (-140.43%).
Metrics side by side
Valuation
| Metric | INVA | KMTS |
|---|---|---|
| P/E ratio | 5.08 | N/A |
| Forward P/E | 8.61 | N/A |
| PEG ratio | 0.49 | N/A |
| P/S ratio | 3.47 | 14.88 |
| P/B ratio | 1.25 | 7.14 |
| EV / EBITDA | 4.90 | N/A |
| FCF yield | 12.25% | N/A |
Profitability
| Metric | INVA | KMTS |
|---|---|---|
| Gross margin | 73.09% | 53.89% |
| Operating margin | 36.66% | -134.48% |
| Net margin | 80.56% | -140.43% |
| ROE | 28.97% | -67.40% |
| ROIC | 8.36% | -47.99% |
Growth (annualized)
| Metric | INVA | KMTS |
|---|---|---|
| Revenue CAGR (5Y) | 3.94% | N/A |
| EPS CAGR (5Y) | 12.71% | N/A |
| FCF CAGR (5Y) | -10.54% | N/A |
| Total return CAGR (5Y) | 4.52% | N/A |
Frequently asked
- Is INVA or KMTS more profitable?
- INVA runs the higher net margin — INVA at 80.56% versus KMTS at -140.43%.
Go deeper
Dig into the metrics
Innoviva P/E ratioInnoviva ROEKestra Medical Technologies ROEInnoviva operating marginKestra Medical Technologies operating marginInnoviva revenue growthKestra Medical Technologies revenue growthInnoviva free cash flowKestra Medical Technologies free cash flow
Innoviva & Kestra Medical Technologies appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.